https://www.bioworld.com/rss en-us http://www.bioworld.com/articles/730204 Tue, 07 Apr 2026 11:00:00 -0400 https://www.bioworld.com/articles/730204-five-drug-vipor-regimen-shows-promise-in-aggressive-blood-cancer PET scans showing before and after treatment with VIPOR Before (top) and after (bottom) treatment with VIPOR. Full-body and cross-sectional PET scans of a patient show large lymphoma tumors (circled in red) that have disappeared with treatment. Credit: Center for Cancer Research/National Cancer Institute http://www.bioworld.com/articles/730126 Thu, 02 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730126-korsana-boosts-alzheimers-work-with-reverse-merger-380m-financing Connecting puzzle pieces http://www.bioworld.com/articles/729980 Wed, 01 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/729980-five-drug-vipor-regimen-shows-promise-in-aggressive-blood-cancer PET scans showing before and after treatment with VIPOR Before (top) and after (bottom) treatment with VIPOR. Full-body and cross-sectional PET scans of a patient show large lymphoma tumors (circled in red) that have disappeared with treatment. Credit: Center for Cancer Research/National Cancer Institute http://www.bioworld.com/articles/729977 Wed, 01 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/729977-korsana-boosts-alzheimers-work-with-reverse-merger-380m-financing Connecting puzzle pieces http://www.bioworld.com/articles/730042 Tue, 31 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/730042-infinimmune-presents-preclinical-data-on-anti-il-22-antibody-for-atopic-dermatitis 3D illustration of antibodies http://www.bioworld.com/articles/729995 Fri, 27 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729995-more-than-two-to-tango-multispecifics-at-esmo-tat Antibodies artwork http://www.bioworld.com/articles/729904 Thu, 26 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729904-idel-raises-104m-for-intracellular-pan-cancer-drug-delivery-tech Cancer cells under magnifying glass http://www.bioworld.com/articles/729899 Thu, 26 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729899-kodiaks-zenkuda-sparkles-in-glow2-bla-filing-next Eye wireframe illustration http://www.bioworld.com/articles/729882 Wed, 25 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729882-sanofi-characterizes-sar-447610-for-tauopathies Brain as light bulb filament http://www.bioworld.com/articles/729880 Wed, 25 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729880-nidb-3101-a-new-anti-tau-biparatopic-antibody-for-ad Tau protein in Alzheimer's disease Tau protein in Alzheimer's disease http://www.bioworld.com/articles/729898 Tue, 24 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729898-excalipoint-closes-687m-seed-round-for-cancer-t-cell-engagers Blue-gray dollar sign http://www.bioworld.com/articles/729897 Tue, 24 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729897-imbiologics-crosses-1b-market-cap-with-kosdaq-debut Ha-Gyong-sik, CEO, Imbiologics Imbiologics CEO Ha-Gyong-sik at the company's IPO ceremony. http://www.bioworld.com/articles/729825 Tue, 24 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729825-immutrin-raises-65m-series-a-to-take-another-run-at-reversing-amyloidosis Heart scientific overlay http://www.bioworld.com/articles/729856 Tue, 24 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729856-financing-at-immutrin-to-advance-antibody-for-attr-cardiomyopathy Colorful illustration of the heart http://www.bioworld.com/articles/729854 Tue, 24 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729854-milestone-in-cdr-life-and-boehringer-ingelheim-partnership http://www.bioworld.com/articles/729810 Mon, 23 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729810-kali-signs-12b-sanofi-deal-for-autoimmune-asset-kt-501 Concept of business partnership http://www.bioworld.com/articles/729808 Mon, 23 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729808-market-roomy-phase-ii-zumi-to-reach-dosing-upside-apogee-in-ad Skin irritation http://www.bioworld.com/articles/729793 Mon, 23 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729793-dll3-targeted-t-cell-therapy-shows-efficacy-in-mtc-models Illustration of cancer cells and immunotherapy treatment http://www.bioworld.com/articles/729763 Fri, 20 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729763-imbiologics-crosses-1b-market-cap-with-kosdaq-debut Ha-Gyong-sik, CEO, Imbiologics Imbiologics CEO Ha-Gyong-sik at the company's IPO ceremony. http://www.bioworld.com/articles/729773 Fri, 20 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729773-first-in-class-anti-trpv6-antibody-for-advanced-prostate-cancer 3D illustration showing presence of tumor inside prostate gland http://www.bioworld.com/articles/729747 Thu, 19 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729747-crossbow-raises-77m-series-b-for-t-cell-mimicking-antibodies Antibodies illustration http://www.bioworld.com/articles/729788 Thu, 19 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729788-excalipoint-closes-687m-seed-round-for-cancer-t-cell-engagers Blue-gray dollar sign http://www.bioworld.com/articles/729560 Wed, 18 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729560-excalipoint-closes-687m-seed-round-for-cancer-t-cell-engagers Blue-gray dollar sign http://www.bioworld.com/articles/729714 Tue, 17 Mar 2026 11:00:00 -0400 https://www.bioworld.com/articles/729714-kanaph-imbiologics-to-kick-off-2026-korea-biotech-med-tech-ipos Ha Gyong sik giving a presentation Ha Gyong-sik, CEO, Imbiologics http://www.bioworld.com/articles/729674 Tue, 17 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729674-alloy-therapeutics-and-abbvie-partner-on-antibody-platform Lab glassware and antibodies art concept http://www.bioworld.com/articles/729672 Tue, 17 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729672-private-placement-at-acumen-to-advance-ebd-program Drug capsule spilling onto brain http://www.bioworld.com/articles/729707 Tue, 17 Mar 2026 08:00:00 -0400 https://www.bioworld.com/articles/729707-mestag-raises-40m-to-take-fibroblast-program-into-phase-i-cancer-trial Fibroblast illustration http://www.bioworld.com/articles/729646 Mon, 16 Mar 2026 09:00:00 -0400 https://www.bioworld.com/articles/729646-china-nmpa-clears-ind-for-akesos-trispecific-antibody Concept art for targeting cancer http://www.bioworld.com/articles/729495 Fri, 13 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729495-kanaph-imbiologics-to-kick-off-2026-korea-biotech-med-tech-ipos Ha Gyong sik giving a presentation Ha Gyong-sik, CEO, Imbiologics http://www.bioworld.com/articles/729480 Thu, 12 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/729480-uk-sets-out-regulatory-pathway-for-biologics-made-in-space Earth from space